.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

ASH Annual Meeting

EP. 1: RESPONSE Trial Validates Ruxolitinib in Polycythemia Vera

December 11th 2014

EP. 2: 2014 ASH Annual Meeting

December 11th 2014

EP. 3: Two Experts Discuss JAK Inhibition in Polycythemia Vera

December 11th 2014

EP. 4: Dr Topp on the Efficacy of Glofitamab Plus R-CHOP in Previously Untreated DLBCL

December 12th 2022

Max S. Topp, MD, discusses the efficacy of the combination of glofitamab plus R-CHOP from a phase 1 trial done in previously untreated patients with diffuse large B-cell lymphoma.